BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 27464624)

  • 1. Bifidobacterial recombinant thymidine kinase-ganciclovir gene therapy system induces FasL and TNFR2 mediated antitumor apoptosis in solid tumors.
    Wang C; Ma Y; Hu Q; Xie T; Wu J; Zeng F; Song F
    BMC Cancer; 2016 Jul; 16():545. PubMed ID: 27464624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous Administration Is an Effective and Safe Route for Cancer Gene Therapy Using the Bifidobacterium-Mediated Recombinant HSV-1 Thymidine Kinase and Ganciclovir.
    Zhou H; He Z; Wang C; Xie T; Liu L; Liu C; Song F; Ma Y
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27275821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bifidobacterium infantis-mediated HSV-TK/GCV suicide gene therapy induces both extrinsic and intrinsic apoptosis in a rat model of bladder cancer.
    Yin X; Yu B; Tang Z; He B; Ren J; Xiao X; Tang W
    Cancer Gene Ther; 2013 Feb; 20(2):77-81. PubMed ID: 23258087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant AAV-mediated HSVtk gene transfer with direct intratumoral injections and Tet-On regulation for implanted human breast cancer.
    Li ZB; Zeng ZJ; Chen Q; Luo SQ; Hu WX
    BMC Cancer; 2006 Mar; 6():66. PubMed ID: 16539746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
    Tang Q; Zhang D; Wan M; Jin L
    Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of Fas (CD95/APO-1) and Fas ligand in apoptosis induced by ganciclovir treatment of tumor cells transduced with herpes simplex virus thymidine kinase.
    Wei SJ; Chao Y; Shih YL; Yang DM; Hung YM; Yang WK
    Gene Ther; 1999 Mar; 6(3):420-31. PubMed ID: 10435092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT3/NF-κB-Regulated Lentiviral TK/GCV Suicide Gene Therapy for Cisplatin-Resistant Triple-Negative Breast Cancer.
    Kuo WY; Hwu L; Wu CY; Lee JS; Chang CW; Liu RS
    Theranostics; 2017; 7(3):647-663. PubMed ID: 28255357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel bystander effect involving tumor cell-derived Fas and FasL interactions following Ad.HSV-tk and Ad.mIL-12 gene therapies in experimental prostate cancer.
    Hall SJ; Canfield SE; Yan Y; Hassen W; Selleck WA; Chen SH
    Gene Ther; 2002 Apr; 9(8):511-7. PubMed ID: 11948376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRAIL enhances thymidine kinase/ganciclovir gene therapy of neuroblastoma cells.
    Beltinger C; Fulda S; Walczak H; Debatin KM
    Cancer Gene Ther; 2002 Apr; 9(4):372-81. PubMed ID: 11960288
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Wang C; Shen Y; Ma Y
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel Bifidobacterium infantis-mediated TK/GCV suicide gene therapy system exhibits antitumor activity in a rat model of bladder cancer.
    Tang W; He Y; Zhou S; Ma Y; Liu G
    J Exp Clin Cancer Res; 2009 Dec; 28(1):155. PubMed ID: 20015348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoscale bubble ultrasound contrast agents-mediated suicide gene therapy system, Nanoscale bubble-LV5-YCD-TK/GCV/5-FC, effectively inhibits bladder cancer cell growth.
    Fu YR; Chen F; Luo Y; Yi YF
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):75-86. PubMed ID: 30657549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential chemosensitivity of breast cancer cells to ganciclovir treatment following adenovirus-mediated herpes simplex virus thymidine kinase gene transfer.
    Li PX; Ngo D; Brade AM; Klamut HJ
    Cancer Gene Ther; 1999; 6(2):179-90. PubMed ID: 10195885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antitumor effect of suicide gene therapy using Bifidobacterium infantis-mediated herpes simplex virus thymidine kinase/ganciclovir in a nude mice model of renal cell carcinoma.
    Xiao X; Jin R; Li J; Bei Y; Wei T
    Urology; 2014 Oct; 84(4):982.e15-20. PubMed ID: 25123427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HSV-TK/GCV cancer suicide gene therapy by a designed recombinant multifunctional vector.
    Wang Y; Canine BF; Hatefi A
    Nanomedicine; 2011 Apr; 7(2):193-200. PubMed ID: 20817124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of thymidine kinase/ganciclovir and cytosine deaminase/ 5-fluorocytosine suicide gene therapy-induced cell death in glioma cells.
    Fischer U; Steffens S; Frank S; Rainov NG; Schulze-Osthoff K; Kramm CM
    Oncogene; 2005 Feb; 24(7):1231-43. PubMed ID: 15592511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Golgi membrane protein GP73 modified-liposome mediates the antitumor effect of survivin promoter-driven HSVtk in hepatocellular carcinoma.
    Liu C; Wen C; Wang X; Wei Y; Xu C; Mu X; Zhang L; Wang X; Tian J; Ma P; Meng F; Zhang Q; Zhao N; Yu B; Gong T; Guo R; Wang H; Xie J; Sun G; Li G; Zhang H; Qin Q; Xu J; Dong X; Wang L
    Exp Cell Res; 2019 Oct; 383(1):111496. PubMed ID: 31306654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxicity of HSVtk and hrTNF-alpha fusion genes with IRES in treatment of gastric cancer.
    Zhang JH; Wan MX; Pan BR; Yu B
    Cancer Biol Ther; 2004 Nov; 3(11):1075-80. PubMed ID: 15477756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus vector-mediated herpes simplex virus-thymidine kinase gene/ganciclovir system exhibits anti-tumor effects in an orthotopic hepatocellular carcinoma model.
    Zhu R; Chen D; Lin D; Lu F; Yin J; Li N
    Pharmazie; 2014 Jul; 69(7):547-52. PubMed ID: 25073402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Herpes simplex virus type 1 thymidine kinase/ganciclovir (HSV(1)-TK/GCV) system as an effective "in vivo death switch" of live tumor vaccines].
    Kang Y; Xu CJ; Liu XS; Wu CQ; Zhong CP; Gu JR
    Ai Zheng; 2005 Aug; 24(8):909-14. PubMed ID: 16086864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.